아토르바스타틴 시장 규모는 향후 수년간 급성장할 것으로 예상됩니다. 고통의 유병률 증가, 높은 콜레스테롤 수치, 심장 질환을 앓고있는 고령화 인구 증가, 콜레스테롤 관리 및 스크리닝 프로그램에 대한 인식 증가, 일반 의사 약품으로서의 아토르바스타틴의 경쟁가격으로의 이용가능성 등에 기인한다고 생각됩니다. 예측기간 중의 주요 동향으로서는 혁신적인 아토르바스타틴 제제의 연구개발에 대한 투자, 제조에 있어서의 그린 케미스트리의 채용, 맞춤형 의료나 약리유전체학에 근거한 치료에의 시프트, 디지털 헬스 기술의 통합, 새로운 아토르바스타틴 제형 등이 있습니다.
심혈관 질환의 유병률 상승은 향후 수년간 아토르바스타틴 시장의 성장을 가속할 것으로 예상됩니다. 이를 통해 심장마비와 뇌졸중과 같은 주요 심혈관 사건의 위험을 크게 줄이는 데 중요한 역할을 하고 있습니다. 예를 들어, 2024년 1월 미국의 비영리 단체인 미국심장협회는 총 심혈관 관련 사망자 수가 전년의 92만 8,741명에서 3,000명 증가한 93만 1,578명으로 소폭 증가했다고 보고했습니다.
아토르바스타틴 시장의 선도 기업들은 고 콜레스테롤과 관련 심혈관 위험 인자의 치료를 강화하기 위해 기성품 액체 경구 현탁액과 같은 혁신적인 제품 개발에 주력하고 있습니다. 이러한 제형은 편리하고 효과적인 약물 투여 수단을 제공하며, 특히 고형제의 삼키기가 어려운 환자에게 유용합니다. 예를 들어 2023년 6월 미국 제약회사 CMP Pharma, Inc.는 미국 식품의약국(FDA)에서 승인한 Atorvaliq(아토르바스타틴 calcium) 경구 현탁액 20mg/5mL를 출시했습니다. Atorvaliq는 아토르바스타틴을 필요로 하는 동안 삼키는 장애와 삼키는 어려움에 직면한 환자에게 특별한 도전입니다. 아토르바릭은 안전하고 편리한 FDA 승인 액체 제형으로 의료 서비스 제공업체 및 대상 환자에게 제공됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염, 그리고 경기 회복이 시장에 미치는 영향을 포함한 거시 경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 아토르바스타틴 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계의 아토르바스타틴 시장 : 성장률 분석
- 세계의 아토르바스타틴 시장 실적 : 규모와 성장(2019-2024년)
- 세계의 아토르바스타틴 시장 예측 : 규모와 성장(2024-2029년, 2034년)
- 세계의 아토르바스타틴 전체 시장(TAM)
제6장 시장 세분화
- 세계의 아토르바스타틴 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 화학합성
- 생촉매 작용
- 세계의 아토르바스타틴 시장 : 치료적 치료별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 심혈관 질환
- 비만
- 염증성 질환
- 기타 치료법
- 세계의 아토르바스타틴 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 병원 약국
- 소매 약국
- 온라인 약국
- 세계의 아토르바스타틴 시장 : 화학합성 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 아토르바스타틴의 전통적인 화학 합성
- 반합성 아토르바스타틴 생산
- 상업적 생산을 위한 대규모 화학 합성
- 세계의 아토르바스타틴 시장 : 생촉매 작용 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 아토르바스타틴의 효소 촉매 합성
- 효율적인 생산을 위한 생촉매 경로
- 아토르바스타틴 제조의 녹색 화학적 접근법
- 보다 높은 수율과 순도를 위한 생촉매법
제7장 지역별/국가별 분석
- 세계의 아토르바스타틴 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 아토르바스타틴 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 아토르바스타틴 시장 : 경쟁 구도
- 아토르바스타틴 시장 : 기업 프로파일
- Zydus Lifesciences 개요, 제품 및 서비스, 전략 및 재무 분석
- Pfizer Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Viatris Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Teva Pharmaceutical Industries Ltd. 개요, 제품 및 서비스, 전략 및 재무 분석
- Hetero Ltd. 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Sun Pharmaceutical Industries Ltd.
- Dr. Reddy's Laboratories Ltd.
- Cadila Pharmaceuticals Ltd.
- Apotex Pharmachem Inc.
- Glenmark Pharmaceuticals Ltd.
- Alembic Pharmaceuticals Ltd.
- Centrient Pharmaceuticals
- Accord Healthcare Ltd.
- Wockhardt Ltd.
- Zhejiang Hisun Pharmaceutical Co. Ltd.
- Unichem Laboratories Ltd.
- Morepen
- Ind-Swift Labs Ltd.
- Smilax Laboratories Limited
- Saneca Pharmaceuticals AS
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 아토르바스타틴 시장(2029년) : 새로운 기회를 제공하는 국가
- 아토르바스타틴 시장(2029년) : 새로운 기회를 제공하는 부문
- 아토르바스타틴 시장(2029년) : 성장 전략
제36장 부록
KTH
Atorvastatin is a statin medication utilized to prevent cardiovascular disease in high-risk individuals and to manage abnormal lipid levels. It plays a crucial role in controlling high cholesterol and reducing the likelihood of cardiovascular diseases, thus serving as a fundamental component in both prevention and treatment of heart disease.
Atorvastatin is produced through two primary methods, chemical synthesis and biocatalysis. Biocatalysis is particularly important in the manufacturing process of atorvastatin, a drug aimed at lowering cholesterol levels. It is employed in diverse therapeutic applications, including cardiovascular disorders, obesity, inflammatory conditions, and others, utilized across various settings such as hospital pharmacies, retail pharmacies, and online pharmacies.
The atorvastatin market research report is one of a series of new reports from The Business Research Company that provides atorvastatin market statistics, including atorvastatin industry global market size, regional shares, competitors with an atorvastatin market share, detailed atorvastatin market segments, market trends, and opportunities, and any further data you may need to thrive in the atorvastatin industry. This atorvastatin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The atorvastatin market size has grown rapidly in recent years. It will grow from $11.86 billion in 2024 to $13.15 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to increased healthcare expenditure, increased incidence of metabolic disorders and obesity worldwide, sedentary lifestyles and unhealthy dietary habits in many populations, lack of physical activity and exercise, increased focus on preventive healthcare and wellness globally.
The atorvastatin market size is expected to see rapid growth in the next few years. It will grow to $19.57 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to growing prevalence of cardiovascular diseases, high cholesterol levels, increasing aging population more susceptible to heart disease, rising awareness about cholesterol management and screening programs, availability of atorvastatin as a generic drug at competitive prices. Major trends in the forecast period include investments in research and development of innovative atorvastatin formulations, adoption of green chemistry in manufacturing, shift towards personalized medicine and pharmacogenomics-based therapy, integration of digital health technologies, new atorvastatin formulations.
The rising prevalence of cardiovascular diseases is anticipated to drive the growth of the atorvastatin market in the coming years. Cardiovascular diseases (CVDs) include various disorders affecting the heart and blood vessels. This increase in cardiovascular diseases is due to a mix of lifestyle changes, demographic trends, and environmental factors. Atorvastatin plays a key role in significantly reducing the risk of major cardiovascular events like heart attacks and strokes by targeting these underlying factors. Its widespread use among patients with high cholesterol and other CVD risk factors has contributed to lowering the overall burden of cardiovascular diseases. For instance, in January 2024, the American Heart Association, a US-based nonprofit organization, reported a slight increase in total cardiovascular-related deaths, totaling 931,578-up by 3,000 from the previous year's 928,741. Thus, the rising prevalence of cardiovascular diseases is fueling growth in the atorvastatin market.
Leading firms in the atorvastatin market are concentrating on developing innovative products such as ready-made liquid oral suspensions to enhance the treatment of high cholesterol and associated cardiovascular risk factors. These formulations provide a convenient and effective means of administering medications, particularly beneficial for patients who have difficulty swallowing solid dosage forms. For instance, in June 2023, CMP Pharma, Inc., an American pharmaceutical company, introduced Atorvaliq (atorvastatin calcium) Oral Suspension, 20 mg/5 mL, approved by the US Food and Drug Administration (FDA). Atorvaliq caters specifically to patients needing atorvastatin but facing dysphagia or swallowing challenges. Its availability offers healthcare providers and eligible patients a safe, convenient, and FDA-approved liquid option.
In August 2023, Aspen Pharmacare Holdings Limited, a pharmaceutical company based in South Africa, acquired Viatris Inc.'s drug products Portfolio for $280 million. This acquisition was a strategic move by Aspen Pharmacare to expand its Portfolio by integrating Viatris's expertise in offering generic and specialty drugs for treating acute and chronic conditions. Viatris Inc., based in the US, provides various forms of pharmaceuticals including atorvastatin for different cardiovascular-related conditions.
Major companies operating in the atorvastatin market are Zydus Lifesciences, Pfizer Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Hetero Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cadila Pharmaceuticals Ltd., Apotex Pharmachem Inc., Glenmark Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Centrient Pharmaceuticals, Accord Healthcare Ltd., Wockhardt Ltd., Zhejiang Hisun Pharmaceutical Co. Ltd., Unichem Laboratories Ltd., Morepen, Ind-Swift Labs Ltd., Smilax Laboratories Limited, Saneca Pharmaceuticals AS, Combi-Blocks Inc., Shree HariKrishna Group, Srini Pharmaceuticals Pvt. Ltd., Suvan Lifesciences Ltd., Zenfold Sustainable Technologies
North America was the largest region in the atorvastatin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atorvastatin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the atorvastatin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The atorvastatin market consists of sales of atorvastatin calcium tablets, extended-release tablets, and generic tablets. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Atorvastatin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on atorvastatin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for atorvastatin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The atorvastatin market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Chemical Synthesis; Biocatalysis
- 2) By Therapeutic Treatment: Cardiovascular Disorders; Obesity; Inflammatory Disorders; Other Therapeutic Treatments
- 3) By Application: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
- Subsegments:
- 1) By Chemical Synthesis: Traditional Chemical Synthesis Of Atorvastatin; Semi-Synthetic Atorvastatin Production; Large-Scale Chemical Synthesis For Commercial Production
- 2) By Biocatalysis: Enzyme-Catalyzed Synthesis Of Atorvastatin; Biocatalytic Pathways For Efficient Production; Green Chemistry Approaches In Atorvastatin Manufacturing; Biocatalysis For Higher Yield And Purity
- Companies Mentioned: Zydus Lifesciences; Pfizer Inc.; Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Hetero Ltd.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Atorvastatin Market Characteristics
3. Atorvastatin Market Trends And Strategies
4. Atorvastatin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Atorvastatin Growth Analysis And Strategic Analysis Framework
- 5.1. Global Atorvastatin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Atorvastatin Market Growth Rate Analysis
- 5.4. Global Atorvastatin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Atorvastatin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Atorvastatin Total Addressable Market (TAM)
6. Atorvastatin Market Segmentation
- 6.1. Global Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Chemical Synthesis
- Biocatalysis
- 6.2. Global Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cardiovascular Disorders
- Obesity
- Inflammatory Disorders
- Other Therapeutic Treatments
- 6.3. Global Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- 6.4. Global Atorvastatin Market, Sub-Segmentation Of Chemical Synthesis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Traditional Chemical Synthesis Of Atorvastatin
- Semi-Synthetic Atorvastatin Production
- Large-Scale Chemical Synthesis For Commercial Production
- 6.5. Global Atorvastatin Market, Sub-Segmentation Of Biocatalysis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Enzyme-Catalyzed Synthesis Of Atorvastatin
- Biocatalytic Pathways For Efficient Production
- Green Chemistry Approaches In Atorvastatin Manufacturing
- Biocatalysis For Higher Yield And Purity
7. Atorvastatin Market Regional And Country Analysis
- 7.1. Global Atorvastatin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Atorvastatin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Atorvastatin Market
- 8.1. Asia-Pacific Atorvastatin Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Atorvastatin Market
- 9.1. China Atorvastatin Market Overview
- 9.2. China Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Atorvastatin Market
- 10.1. India Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Atorvastatin Market
- 11.1. Japan Atorvastatin Market Overview
- 11.2. Japan Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Atorvastatin Market
- 12.1. Australia Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Atorvastatin Market
- 13.1. Indonesia Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Atorvastatin Market
- 14.1. South Korea Atorvastatin Market Overview
- 14.2. South Korea Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Atorvastatin Market
- 15.1. Western Europe Atorvastatin Market Overview
- 15.2. Western Europe Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Atorvastatin Market
- 16.1. UK Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Atorvastatin Market
- 17.1. Germany Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Atorvastatin Market
- 18.1. France Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Atorvastatin Market
- 19.1. Italy Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Atorvastatin Market
- 20.1. Spain Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Atorvastatin Market
- 21.1. Eastern Europe Atorvastatin Market Overview
- 21.2. Eastern Europe Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Atorvastatin Market
- 22.1. Russia Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Atorvastatin Market
- 23.1. North America Atorvastatin Market Overview
- 23.2. North America Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Atorvastatin Market
- 24.1. USA Atorvastatin Market Overview
- 24.2. USA Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Atorvastatin Market
- 25.1. Canada Atorvastatin Market Overview
- 25.2. Canada Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Atorvastatin Market
- 26.1. South America Atorvastatin Market Overview
- 26.2. South America Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Atorvastatin Market
- 27.1. Brazil Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Atorvastatin Market
- 28.1. Middle East Atorvastatin Market Overview
- 28.2. Middle East Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Atorvastatin Market
- 29.1. Africa Atorvastatin Market Overview
- 29.2. Africa Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Atorvastatin Market Competitive Landscape And Company Profiles
- 30.1. Atorvastatin Market Competitive Landscape
- 30.2. Atorvastatin Market Company Profiles
- 30.2.1. Zydus Lifesciences Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Hetero Ltd. Overview, Products and Services, Strategy and Financial Analysis
31. Atorvastatin Market Other Major And Innovative Companies
- 31.1. Sun Pharmaceutical Industries Ltd.
- 31.2. Dr. Reddy's Laboratories Ltd.
- 31.3. Cadila Pharmaceuticals Ltd.
- 31.4. Apotex Pharmachem Inc.
- 31.5. Glenmark Pharmaceuticals Ltd.
- 31.6. Alembic Pharmaceuticals Ltd.
- 31.7. Centrient Pharmaceuticals
- 31.8. Accord Healthcare Ltd.
- 31.9. Wockhardt Ltd.
- 31.10. Zhejiang Hisun Pharmaceutical Co. Ltd.
- 31.11. Unichem Laboratories Ltd.
- 31.12. Morepen
- 31.13. Ind-Swift Labs Ltd.
- 31.14. Smilax Laboratories Limited
- 31.15. Saneca Pharmaceuticals AS
32. Global Atorvastatin Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Atorvastatin Market
34. Recent Developments In The Atorvastatin Market
35. Atorvastatin Market High Potential Countries, Segments and Strategies
- 35.1 Atorvastatin Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Atorvastatin Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Atorvastatin Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
